Laboratoire d'Immunogénétique Moléculaire, EA 3034, Faculté de Médecine Purpan, Université Paul Sabatier, Toulouse 3, IFR150 INSERM, Avenue Jean Poulhès, TSA 50032, 31059 Toulouse cedex 9, France.
J Immunol Methods. 2013 Apr 30;390(1-2):41-51. doi: 10.1016/j.jim.2013.01.007. Epub 2013 Jan 24.
Two chimeric monoclonal antibodies (MoAbs) were designed with variable parts of the mouse antibodies W6/32 and F3.3, and the human constant parts C-gamma1 and C-kappa. These chimeric MoAbs are specific for HLA-class I and HLA-class II public epitopes, respectively. The anti-class I MoAb recognizes all HLA-class I tested so far, and the anti-class II MoAb recognize all HLA-DR, DP, and only DQ antigens of the DQ2 subgroup. These Moabs were used as positive controls in routine tests for the detection of IgG anti-HLA antibodies in the sera of patients (Luminex, flow cytometry, and complement-dependent lymphocytotoxicity assay: CD-LCT). In tests with the LABScreen MIX assay, serial dilutions of the two MoAbs have allowed to determine the thresholds of detection by the Boltzmann sigmoidal regression. The thresholds of detection in mean of fluorescence intensity (MFI) were 926 and 866 for the anti-class I MoAb and the anti-class II MoAb, respectively. The thresholds defined as mean+3SD of MFI values obtained with 30 negative control sera were 411 and 251 for the anti-class I beads and the anti-class II beads, respectively. For the daily validation of the anti-HLA IgG antibodies screening by LABScreen MIX we decided to use the positive control MoAbs at three concentrations (5, 50, and 500ng/ml) and we measured the repeatability (<10%) and reproducibility (<16%) of the method. Used as positive controls in tests with the LABScreen Single Antigen kit, the two MoAbs allowed to estimate daily the quality of beads coated with HLA antigens. The two anti HLA MoAbs were also used as positive control in the cross-match assay by flow cytometry or CD-LCT. In total these two chimeric anti-HLA-MoAbs, which have no equivalent so far, are valuable positive controls for the daily validations of most techniques used for the detection of anti-HLA antibodies according to the good practice guidelines for laboratories.
两种嵌合单克隆抗体(MoAb)是利用小鼠抗体 W6/32 和 F3.3 的可变部分和人恒定部分 C-gamma1 和 C-kappa 设计的。这两种嵌合 MoAb 分别针对 HLA Ⅰ类和 HLA Ⅱ类公共表位。抗 HLA Ⅰ类 MoAb 识别迄今为止测试的所有 HLA Ⅰ类,抗 HLA Ⅱ类 MoAb 识别 HLA-DR、DP 以及仅 DQ2 亚组的 DQ 抗原。这些 MoAb 被用作患者血清中 IgG 抗 HLA 抗体检测的常规测试的阳性对照(Luminex、流式细胞术和补体依赖性淋巴细胞毒性试验:CD-LCT)。在 LABScreen MIX assay 测试中,两种 MoAb 的系列稀释允许通过 Boltzmann sigmoidal 回归确定检测的阈值。抗 HLA Ⅰ类 MoAb 和抗 HLA Ⅱ类 MoAb 的平均荧光强度(MFI)检测阈值分别为 926 和 866。通过 30 份阴性对照血清获得的 MFI 值的平均+3SD 定义为抗 HLA Ⅰ类珠和抗 HLA Ⅱ类珠的检测阈值,分别为 411 和 251。为了每日验证 LABScreen MIX 对 HLA IgG 抗体的筛选,我们决定使用三种浓度(5、50 和 500ng/ml)的阳性对照 MoAb,并测量方法的重复性(<10%)和再现性(<16%)。在使用 LABScreen 单抗原试剂盒的测试中,两种 MoAb 可用于估计每日 HLA 抗原包被珠的质量。在流式细胞术或 CD-LCT 的交叉配型试验中,两种抗 HLA MoAb 也被用作阳性对照。总之,这两种嵌合抗 HLA-MoAb 迄今为止尚无等效物,是实验室检测抗 HLA 抗体的大多数技术日常验证的有价值的阳性对照,符合良好实践指南。